Epigenetic aberrations during oncogenesis. (Q37830385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Epigenetic aberrations during oncogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Dimitrios Iliopoulos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

20 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1681-1702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

The history of cancer epigenetics

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The epigenetic progenitor origin of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Genetic predisposition to colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Tumor-initiating and -propagating cells: cells that we would like to identify and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

21 January 2018

Stem cells and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

DNA methylation patterns and epigenetic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

DNA methylation landscapes: provocative insights from epigenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Hypomethylation distinguishes genes of some human cancers from their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The necessity of a human epigenome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Gene silencing in cancer in association with promoter hypermethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Cancer epigenomics: DNA methylomes and histone-modification maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Induction of Tumors in Mice by Genomic Hypomethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Unanswered Questions about the Role of Promoter Methylation in Carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

PTEN promoter methylation in sporadic thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromatin-modifying proteins in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Expression profile of histone deacetylase 1 in gastric cancer tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Expression of HDAC1 and CBP/p300 in human colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Increased expression of histone deacetylase 2 is found in human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

HDAC6 expression is correlated with better survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromatin modification, leukaemia and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Poly(ADP‐ribose) and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The ING gene family in the regulation of cell growth and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Functional analysis of the transcription repressor PLU-1/JARID1B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Roles of the EZH2 histone methyltransferase in cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Crystal structure of the nucleosome core particle at 2.8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The constantly changing face of chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Deacetylase enzymes: biological functions and the use of small-molecule inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

An epigenetic road map for histone lysine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The JmjC domain histone demethylase Ndy1 regulates redox homeostasis and protects cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromatin modifications and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Complicated tails: histone modifications and the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Towards the human cancer epigenome: a first draft of histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Global histone modification patterns predict risk of prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetics: reversing the 'irreversible'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Differential expression of selected histone modifier genes in human solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Nucleosome positioning and gene regulation: advances through genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Nucleosome stability mediated by histone variants H3.3 and H2A.Z.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Regulation of gene expression and cellular proliferation by histone H2A.Z.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Abundant conserved microRNA target sites in the 5'-untranslated region and coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

microRNA and stem cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNAs and cancer: short RNAs go a long way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Rapid alteration of microRNA levels by histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic regulation of microRNAs in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

miR-148 targets human DNMT3b protein coding region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Binding reactions: epigenetic switches, signal transduction and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

DNA hypermethylation of myeloid cells, a novel therapeutic target in MDS and AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Treatment options in advanced myelodysplastic syndrome, with emphasis on epigenetic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Comment on "Chromosomal instability and tumors promoted by DNA hypomethylation" and "Induction of tumors in nice by genomic hypomethylation".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromatin, cancer and drug therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Differentiation of erythroleukemic cells in the presence of inhibitors of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Histone deacetylases and the immunological network: implications in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Discovery and development of SAHA as an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Decitabine--bedside to bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Drug reactivates genes to inhibit cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Enhancing the apoptotic and therapeutic effects of HDAC inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

The changing face of HDAC inhibitor depsipeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-010-0624-Z

Chromosomal Instability and Tumors Promoted by DNA Hypomethylation

21 January 2018

1 reference

12 December 2020

Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.

1 reference

12 December 2020

Mendel stayed home. Genomic imprinting and environmental disease susceptibility, National Institute of Environmental Health Sciences and Duke University Medical Center, Durham, NC, USA, 8-10 October 1998

1 reference

12 December 2020

Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

1 reference

12 December 2020

Reduced genomic 5-methylcytosine content in human colonic neoplasia

1 reference

12 December 2020

Frequent hypermethylation of p16 and p15 genes in multiple myeloma

1 reference

12 December 2020

Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor

1 reference

12 December 2020

Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks

1 reference

12 December 2020

p300 gene alterations in colorectal and gastric carcinomas.

1 reference

12 December 2020

Mutations and deletions of the CBP gene in human lung cancer.

1 reference

12 December 2020

Requirement of Pygopus 2 in breast cancer

1 reference

12 December 2020

Increased cytosine DNA-methyltransferase activity during colon cancer progression

1 reference

12 December 2020

Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis

1 reference

12 December 2020

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

1 reference

12 December 2020

Worms gang up on bacteria

1 reference

12 December 2020

Methylation of the BRCA1 gene in sporadic breast cancer

1 reference

12 December 2020

Epigenetic regulation of miR-196b expression in gastric cancer

1 reference

12 December 2020

Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.

1 reference

12 December 2020

A direct link between core histone acetylation and transcriptionally active chromatin

1 reference

12 December 2020

Expression of poly(ADP-ribose) polymerase in human hepatocellular carcinoma and analysis of biopsy specimens obtained under sonographic guidance

1 reference

12 December 2020

LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

1 reference

12 December 2020

DNA hypomethylation and human diseases.

1 reference

12 December 2020

Predicting lung cancer by detecting aberrant promoter methylation in sputum

1 reference

12 December 2020

Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer

1 reference

12 December 2020

Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma

1 reference

12 December 2020

Epigenetic cancer therapy makes headway

1 reference

12 December 2020

Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide

1 reference

12 December 2020

CpG island hypermethylation of tumor suppressor microRNAs in human cancer

1 reference

12 December 2020

Epigenetic regulation of cancer growth by histone demethylases

1 reference

12 December 2020

Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression

1 reference

12 December 2020

Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer

1 reference

12 December 2020

Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas

1 reference

12 December 2020

Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation

1 reference

12 December 2020

BRCA1 promoter methylation predicts adverse ovarian cancer prognosis

1 reference

12 December 2020

Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients

1 reference

12 December 2020

Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene

1 reference

12 December 2020

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S00018-010-0624-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249513%20AND%20SRC:MED&resulttype=core&format=json

release_sq3no6sp5bbqpgo66m7zwmijaa

20 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sq3no6sp5bbqpgo66m7zwmijaa

24 November 2022

mapped directly with Wikidata item

1 reference